Skip to main content
SpringerLink
Log in

Anticoagulant therapy and atrial fibrillation

  • Chapter
Anticoagulation

  • 57 Accesses

Abstract

Atrial fibrillation (AF) is one of the most common cardiac arrhytmias but the only one known to be associated with an increased risk of systemic embolism (SE).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bjerkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation. Am J Cardiol 23, 208–216, 1969.

    Article  PubMed  CAS  Google Scholar 

  2. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation: 30 — year follow up in the Framingham study. JAMA 254, 3449–3453, 1985.

    Article  PubMed  CAS  Google Scholar 

  3. Cabin HS, Clubb KS, Hall C, Perlmutter RA, Feinstein AR. Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol 65, 1112–1116, 1990.

    Article  PubMed  CAS  Google Scholar 

  4. Camm AJ, Katritsis D. Ventricular pacing for sick sinus syndrome: a risky Business? Pace 13, 695–699, 1990.

    Article  PubMed  CAS  Google Scholar 

  5. Castello R, Pearson AC, Labovitz AS, Lenzen P. Prevalence and clinical implication of atrial spontaneous contrast in patients undergoing transesophageal echocardiography. Am J Cardiol 65, 1149–1153, 1990.

    Article  PubMed  CAS  Google Scholar 

  6. Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol 43, 71–84, 1986.

    Google Scholar 

  7. Chesebro J, Fuster V, Halperin JL. Atrial fibrillation. Risk marker for stroke. N Engl J Med 323, 1556–1558, 1990.

    Article  PubMed  CAS  Google Scholar 

  8. Ezekowitz MD, Bridgers SL, James KE and SPINAF Investigators. Interim analysis of VA cooperative study. Stroke prevention in non-rheumatic atrial fibrillation. (SPINAF). Circulation II, 450, 1991.

    Google Scholar 

  9. Fairfax AJ, Lambert CD, Leatham A. Systemic embolism in chronic sinatrial disease. N Engl J Med 295, 190–192, 1976.

    Article  PubMed  CAS  Google Scholar 

  10. Fisher CM. Embolism in atrial fibrillation. In: Kulbertus HB, Olson SB, Schlepper M (Eds). Atrial Fibrillation. Hassle AB, Molndal, Sweden, 1982.

    Google Scholar 

  11. Harrisson MJG, Marshall J. Atrial fibrillation, TIAs and completed strokes. Stroke 15, 441–442, 1984.

    Article  Google Scholar 

  12. Hart RG, Coull BM, Hart D. Early recurrent embolism associated with non-valvular atrial fibrillation: a retrospective study. Stroke 14, 688–693, 1983.

    Article  PubMed  CAS  Google Scholar 

  13. Kannel WB, Abbott RD, Savage DD, Mc Namara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 306, 1018–1022, 1982.

    CAS  Google Scholar 

  14. Kopecky SL, Gersh BI, Mc Goon MD, Whisnant JP, Holmes Dr Jr, Ilstrup DM, Frye RL. The natural history of lone atrial fibrillation: a population based study over three decades. N Engl J Med 317, 669–674, 1987.

    Article  PubMed  CAS  Google Scholar 

  15. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N. Increased intracardiovascular clotting in patients with chronic atrial fibrillation. JACC 16, 377–380, 1990.

    PubMed  CAS  Google Scholar 

  16. Landefeld CS. Major bleeding in outpatients treated with warfarin: incidence and prediction of factors known at the start of outpatient therapy. Am J Med 87, 144, 1989.

    Article  PubMed  CAS  Google Scholar 

  17. Petersen P, Boyssen G, Godtfredsen J, Andersen ED, Andersen B. Placebo controlled randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1, 175–179, 1989.

    Article  PubMed  CAS  Google Scholar 

  18. Petersen P, Rastrup J, Helweg-Larsen S, Boyssen G, Godtfredsen S. Risk factors for thromboembolic complication in chronic atrial fibrillation. The Copenhagen AFASAK Study. Arch Intern Med 150, 819–821, 1990.

    CAS  Google Scholar 

  19. Sage JL, Van Uitert RL. Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease. Stroke 14, 537–540, 1983.

    Article  PubMed  CAS  Google Scholar 

  20. Santini M, Alexidou G, Ansalone G, Cacciatore G, Cini R, Turitto G. Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing. Am J Cardiol 65, 729–735, 1990.

    Article  PubMed  CAS  Google Scholar 

  21. Scheinman MM, Morady F, Hess DS, Gonzalez R. Catheter — induced ablation of the atrioventricular junction to control refractory supraventricular arrhytmia. JAMA 248, 851–855, 1982.

    Article  PubMed  CAS  Google Scholar 

  22. Stein B, Fuster V, Halperin JL, Chesebro JH. Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk. Circulation 80 1501–1513, 1989.

    CAS  Google Scholar 

  23. Stroke prevention in atrial fibrillation study group investigators. Preliminary report of the stroke prevention in atrial fibrillation study. N Engl J Med 3322, 863–868, 1990.

    Google Scholar 

  24. Sutton R, Kenny RA. The natural history of sick sinus syndrome. Pace 9, 1110, 1986.

    Article  PubMed  CAS  Google Scholar 

  25. Tegeler CH. Stroke prevention in atrial fibrillation study: Carotid Stenosis Study Group. Carotid stenosis in atrial fibrillation. Neurology 39(1), 159 (Abstr.), 1989.

    Google Scholar 

  26. The Boston Area—Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 323, 1505–1511, 1990.

    Article  Google Scholar 

Download references

Authors
  1. Ph. Le Métayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Puel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Haissaguerre
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. F. Warin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Laboratoire d’Hematologie, 3, Place de la Victoire, 33076, Bordeaux cedex, France

    Christian Doutremepuich

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Le Métayer, P., Puel, V., Haissaguerre, M., Warin, J.F. (1994). Anticoagulant therapy and atrial fibrillation. In: Doutremepuich, C. (eds) Anticoagulation. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2668-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2668-0_17

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7627-2

  • Online ISBN: 978-1-4612-2668-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation